B. Leonard

B. Leonard, S. Tang, W. Tang, 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

SSRIs and movement disorders: is serotonin the culprit?

B. Leonard, C. Faherty, 1996 .

Depression, stress and immunological activation: the role of cytokines in depressive disorders.

B. Leonard, T. Connor, 1998, Life sciences.

Noradrenaline and animal cognitive processes: implications for dementia

B. Leonard, P. Moran, 1989, Irish Journal of Psychological Medicine.

Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat.

B. Leonard, M. Tuite, 1981, International review of neurobiology.

Treatment induced Mood Switching in Affective Disorders.

B. Leonard, S. Tang, W. Tang, 2021, Acta neuropsychiatrica.

Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats.

B. Leonard, H. Riezen, H. van Riezen, 1990, Pharmacology & therapeutics.

The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment.

B. Leonard, A. Harkin, C. Faherty, 1998, European journal of pharmacology.

Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat

B. Leonard, B. Earley, C. Faherty, 1997, Journal of psychopharmacology.

The olfactory bulbectomised rat as a model of depression

B. Leonard, Cai Song, 2005, Neuroscience & Biobehavioral Reviews.

Monoamines in brain and urine of rats with hereditary hypothalamic diabetes insipidus

B. Leonard, H. Rigter, F. Ramaekers, 2005, Experientia.

The effect of the chronic administration of barbitone sodium on labile compounds in the rat brain.

B. Leonard, 1966, Biochemical pharmacology.

The effect of d-amphetamine and amitriptyline administered to pregnant rats on the locomotor activity and neurotransmitters of the offspring

B. Leonard, V. Bigl, D. Biesold, 2004, Psychopharmacology.

B. Leonard, B. Kennedy, 1980, Biochemical Society transactions.

The effect of the chronic administration of D‐amphetamine upon circadian changes in amino acids in the pineal and pituitary glands of the rat

V. Neuhoff, B. Leonard, S. Tonge, 1974, Zeitschrift fur Naturforschung. Section C, Biosciences.

Monoamine transport in depression: kinetics and dynamics.

B. Leonard, D. Healy, Brian E. Leonard, 1987, Journal of affective disorders.

Biological markers of serotonin receptors in depression and animal models of depression

B. Leonard, 1995 .

Biochemical Strategies for the Development of Antidepressants

B. Leonard, 1994 .

Effect of Antidepressants on Neurotransmission: a Common Mechanism of Action?

B. Leonard, 1992 .

Biological Markers of Depression

B. Leonard, T. Connor, 2004 .

Inter-relationship between neurotransmitters

B. Leonard, 1984, Neuropharmacology.

Changes in platelet 5-hydroxytryptamine uptake in mania.

B. Leonard, A. O'Halloran, P. A. Carney, 1990, Journal of affective disorders.

Changes in platelet Shydroxytryptamine uptake in mania

B. Leonard, A. O'Halloran, J. Meagher, 1990 .

Efavirenz Induces Depressive-Like Behaviour, Increased Stress Response and Changes in the Immune Response in Rats

H. Steinbusch, B. Leonard, A. Myint, 2005, Neuroimmunomodulation.

The effect of audiogenic seizures on labile nitrogen and phosphorus containing compounds in the rat brain.

B. Leonard, 1965, Biochemical pharmacology.

Effect of Chronic Treatment with Piracetam and Tacrine on Some Changes Caused by Thymectomy in the Rat Brain

B. Leonard, Cai Song, B. Earley, 1997, Pharmacology Biochemistry and Behavior.

The effect of stressful behavioural exposure on endocrine and immune parameters in the rat

J. Kelly, B. Leonard, Cai Song, 1994 .

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

M. Maes, L. Goehler, B. Leonard, 2012, BMC Medicine.

Effects of JO 1784, A selective sigma ligand, on the autoradiographic localization of M2 and M2 muscarinic receptor subtypes in trimethyltin treated rats

B. Leonard, B. Earley, J. Junien, 1995, Neurochemistry International.

Translational Strategies for Developing Biomarkers for Major Depression: Lessons Learned from Animal Models

B. Leonard, F. Aricioglu, 2022, Neuromethods.

The σ ligand JO 1784 Prevents Trimethyltin‐Induced Behavioural and σ‐Receptor Dysfunction in the Rat

B. Leonard, B. Earley, A. O'Connell, 1996 .

The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat

B. Leonard, B. Earley, A. O'Connell, 1994, Neurochemistry International.

Effects of the GABA agonist THIP (gaboxadol) on trimethyltin-induced behavioural neurotoxicity in the rat

B. Leonard, B. Earley, A. O'Connell, 1994 .

Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat

B. Leonard, B. Earley, M. Burke, 1992, Neurochemistry International.

A comparison of the psychopharmacological profiles of phencyclidine, ketamine and (+) SKF 10,047 in the trimethyltin rat model

B. Leonard, B. Earley, J. Junien, 1990, Neuropharmacology.

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

B. Leonard, M. Berk, M. Kubera, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression

Yong-Ku Kim, Kyoung-Sae Na, B. Leonard, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

THE PHARMACOLOGY OF THE PHENOTHIAZINES, BUTYROPHENONES, THIOXANTHINES AND DIPHENYLBUTYLPIPERIDINES

B. Leonard, 1993 .

The HPA and immune axes in stress: the involvement of the serotonergic system

B. Leonard, 2005, European Psychiatry.

Th1, Th2, and Th3 cytokine alterations in major depression.

H. Steinbusch, B. Leonard, Yong-Ku Kim, 2005, Journal of affective disorders.

Stress, the immune system and psychiatric illness

B. Leonard, 1988 .

The immune system and depression

B. Leonard, 1988 .

Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression.

B. Leonard, B. O'Neill, Bernadette O’Neill, 1990, Journal of affective disorders.

Behavioral, Neurochemical, and Immunological Responses to CRF Administration a

B. Leonard, Cai Song, B. Earley, 1995 .

Gestational Stress Leads to Depressive-Like Behavioural and Immunological Changes in the Rat

H. Steinbusch, B. Leonard, L. Desbonnet, 2006, Neuroimmunomodulation.

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

B. Leonard, M. Schwarz, A. Myint, 2012, Journal of psychopharmacology.

The psychoneuroimmunology of depression

B. Leonard, A. Myint, 2009, Human psychopharmacology.

Neuropsychiatric disorders related to interferon and interleukins treatment

H. Steinbusch, B. Leonard, M. Schwarz, 2009, Metabolic Brain Disease.

HPA and Immune Axes in Stress: Involvement of the Serotonergic System

B. Leonard, 2007, Neuroimmunomodulation.

Royal academy of medicine in Ireland section of biomedical sciences Proceedings of Summer Meeting held June, 1994

D. Egan, O. Hardiman, J. Kelly, 1994 .

Prolonged c-Jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset.

J. Korf, A. S. Wrynn, B. Leonard, 2000, Brain research. Molecular brain research.

The olfactory bulbectomized rat as a model of depression.

B. Leonard, 1984, Polish journal of pharmacology and pharmacy.

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

M. Maes, B. Leonard, 2012, Neuroscience & Biobehavioral Reviews.

Effects of antidepressants on cytokine production and actions

N. Castanon, B. Leonard, P. Neveu, 2002, Brain, Behavior, and Immunity.

An acute phase protein response in the olfactory bulbectomised rat : effect of sertraline treatment

B. Leonard, Cai Song, 1994 .

Comparative effects of serotonergic agonists withvarying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100635

J. Kelly, B. Leonard, J. Cryan, 1999, Journal of psychopharmacology.

Pain, Depression and Inflammation: Are Interconnected Causative Factors Involved?

B. Leonard, 2015, Modern trends in pharmacopsychiatry.

Androgens, estrogens and their anti-hormones: Effects on body weight and food consumption

B. Leonard, C. Earley, 1979, Pharmacology Biochemistry and Behavior.

The effect of testosterone and cyproterone acetate on the concentration of γ-aminobutyric acid in brain areas of aggressive and non-aggressive mice

B. Leonard, C. Earley, 1977, Pharmacology Biochemistry and Behavior.

Androgenic involvement in conditioned taste aversion

B. Leonard, C. Earley, 1978, Hormones and Behavior.

Is ethanol a neurotoxin?: The effects of ethanol on neuronal structure and function.

B. Leonard, 1986, Alcohol and alcoholism.

Neurochemical effects of amphetamines adrenaline in the brain by increasing the release of this amine from neurons

B. Leonard, S. A. Shallice, S. Shallice, 2006 .

Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain

B. Leonard, 1973, Psychopharmacologia.

The effects of strain differences and emotional status of rats on the behavioural and neurochemical effects of chronic treatment with apomorphine.

B. Leonard, M. Kenny, 1980, Progress in neuro-psychopharmacology.

Changes in brain monoamine metabolism and carbon dioxide induced amnesia in the rat

B. Leonard, H. Rigter, 1975, Pharmacology Biochemistry and Behavior.

Hippocampal monoamine metabolism and the CO2 induced retrograde amnesia gradient in rats

B. Leonard, H. Rigter, G. Eys, 1975, Pharmacology Biochemistry and Behavior.

The effects of some tryptamine derivatives on brain monoamines and their precursor amino acids.

B. Leonard, S. A. Shallice, 1972, Neuropharmacology.

Some effects of an hallucinogenic drug (phencyclidine) on neurohumoral substances.

B. Leonard, S. Tonge, 1970, Life sciences. Pt. 1: Physiology and pharmacology.

The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain.

B. Leonard, S. Tonge, 1969, Life sciences.

Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings].

B. Leonard, A. Morinan, 1977, British journal of pharmacology.

The effect of amitriptyline and mianserine (Org. GB94) on food motivated behaviour of rats trained in a runway: Possible correlation with biogenic amine concentration in the limbic system

B. Leonard, C. Earley, J. Egan, 1979, Psychopharmacology.

Neurochemical and neuropharmacological aspects of depression.

B. Leonard, 1975, International review of neurobiology.

Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat

B. Leonard, S. Jancsár, 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Pharmacological Differences of Serotonin Reuptake Inhibitors and Possible Clinical Relevance

B. Leonard, 2012, Drugs.

Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats

H. Steinbusch, B. Leonard, M. Kubera, 2007 .

Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action.

J. Kelly, B. Leonard, J. Cryan, 2000, European journal of pharmacology.

Effect of experimentally induced seizures on some amino acids and ammonia in rat brain.

B. Leonard, M. Palfreyman, 1972, Biochemical pharmacology.

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients

H. Steinbusch, B. Leonard, Yong-Ku Kim, 2004, Psychiatry Research.

Th1, Th2 and Th3 cytokine alteration in schizophrenia

B. Leonard, Yong-Ku Kim, A. Myint, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

New component of the limbic system: Marginal division of the neostriatum that links the limbic system to the basal nucleus of Meynert

B. Leonard, Jun Wang, S. Shu, 2003, Journal of neuroscience research.

Dietary Ethyl-eicosapentaenoic Acid but not Soybean Oil Reverses Central Interleukin-1-induced Changes in Behavior, Corticosterone and Immune Response in Rats

B. Leonard, D. Horrobin, Cai Song, 2004, Stress.

induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation

T. Harkany, J. Kelly, B. Leonard, 1998 .

Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders

B. Leonard, C. Mcdonald, D. Cannon, 2011 .

Non-pharmacological and pharmacological approaches for psychiatric disorders: Re-appraisal and insights from zebrafish models

B. Leonard, B. Harvey, A. Kalueff, 2020, Pharmacology Biochemistry and Behavior.

The effect of some beta-adrenergic blocking and other drugs on brain lactate levels following electroshock.

B. Leonard, 1971, Neuropharmacology.

The effect of lofepramine and other related agents on the motility of Tetrahymena pyriformis.

J. Kelly, B. Leonard, J. Henry, 2002, Toxicology letters.

SSRI differentiation: Pharmacology and pharmacokinetics

B. Leonard, 1995, Human psychopharmacology.

A review of the role of serotonin receptors in psychiatric disorders

B. Leonard, M. Naughton, Marie Naughton, 2000, Human psychopharmacology.

Stress, norepinephrine and depression

B. Leonard, 2002, Acta Neuropsychiatrica.

Major Depression as a Neuroprogressive Prelude to Dementia: What Is the Evidence?

B. Leonard, 2017, Modern trends in pharmacopsychiatry.

Cannabis: a short review of its effects and the possible dangers of its use.

B. Leonard, 1969, The British journal of addiction to alcohol and other drugs.

The role of noradrenaline in depression: a review.

B. Leonard, B E Leonard, 1997, Journal of psychopharmacology.

The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat.

B. Leonard, M. Caldwell, H. Allain, 1996, Neuropsychobiology.

Induction of two distinct behavioural responses by chronic treatment with apomorphine

B. Leonard, M. Kenny, Marina Lynch, 1980, Journal of neuroscience research.

Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats

B. Leonard, M. Caldwell, H. Allain, 1997, Brain Research.

An investigation of the antidepressant properties of lofepramine and its desmethylated metabolites in the forced swim and olfactory bulbectomized rat models of depression

J. Kelly, B. Leonard, 1999, European Neuropsychopharmacology.

Higher than recommended dosages of antipsychotics in male patients with schizophrenia are associated with increased depression but no major neurocognitive side effects: Results of a cross-sectional pilot naturalistic study

S. Kasper, B. Leonard, K. Fountoulakis, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication

B. Leonard, B. Earley, A. O'Connell, 1994, Neurochemistry International.

Drug Treatment of Mania

B. Leonard, 2004 .

Inflammation, insulin resistance and the pathophysiology of depression: implications for novel antidepressant developments

B. Leonard, F. Aricioglu, 2020 .

Inflammation, insulin resistance and neuroprogression in depression

B. Leonard, G. Wegener, 2019, Acta Neuropsychiatrica.

Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test

J. Kelly, B. Leonard, C. Sánchez, 2003, Psychoneuroendocrinology.

Olfactory Bulbectomy Provokes a Suppression of Interleukin-1β and Tumour Necrosis Factor-α Production in Response to an in vivo Challenge with Lipopolysaccharide: Effect of Chronic Desipramine Treatment

J. Kelly, B. Leonard, T. Connor, 1999, Neuroimmunomodulation.

Peripheral markers of depression

B. Leonard, 2000 .

Inflammation, Depression and Dementia: Are they Connected?

B. Leonard, 2007, Neurochemical Research.

Unraveling the complex interplay of immunometabolic systems that contribute to the neuroprogression of psychiatric disorders

B. Leonard, A. Halaris, 2019, Neurology, Psychiatry and Brain Research.

Some effects of 4-hydroxybutyric acid on brain carbohydrate metabolism.

B. Leonard, W. D. Watkinson, 1971, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

The usefulness and use of second-generation antipsychotic medications: Review of evidence and recommendations by a Task Force of the World Psychiatric Association.

D. Kupfer, T. Crow, J. Lieberman, 2002 .

Inflammation and depression: a causal or coincidental link to the pathophysiology?

B. Leonard, 2017, Acta Neuropsychiatrica.

An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat

H. Anisman, B. Leonard, T. Connor, 1998, Neuroscience.

Nutrition, Brain Aging, and Alzheimers Disease

Rena Li, B. Leonard, Phillip Cao, 2005 .

Differential Effects of Antidepressants

B. Leonard, D. Healy, 1999 .

Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants

B. Leonard, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review

B. Leonard, D. Helmeste, S. Tang, 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Effect of the COX-2 Inhibitor Celecoxib on Behavioural and Immune Changes in an Olfactory Bulbectomised Rat Model of Depression

H. Steinbusch, B. Leonard, A. Myint, 2007, Neuroimmunomodulation.

Tryptophan breakdown pathway in bipolar mania.

H. Steinbusch, B. Leonard, Yong-Ku Kim, 2007, Journal of affective disorders.

Changes in the immune system in depression and dementia: causal or coincidental effects?

B. Leonard, A. Myint, 2006, Dialogues in clinical neuroscience.

Hippocampal Long-Term Potentiation Attenuated by Lesions in the Marginal Division of Neostriatum

Brian Leonard, B. Leonard, Jun Wang, 2003, Neurochemical Research.

Imbalance between Pro- and Anti-inflammatory Cytokines, and between Th1 and Th2 Cytokines in Depressed Patients: The Effect of Electroacupuncture or Fluoxetine Treatment

B. Leonard, C. Song, U. Halbreich, 2009, Pharmacopsychiatry.

Consequences of reward and nonreward conditions: Runaway behavior, neurotransmitters and physiological indicators of stress

B. Leonard, C. Earley, 1979, Pharmacology Biochemistry and Behavior.

5‐HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response

B. Leonard, J. Cryan, John F. Cryan, 2000, Human psychopharmacology.

Malaria, mental disorders, immunity and their inter-relationships - A cross sectional study in a household population in a health and demographic surveillance site in Kenya

B. Leonard, R. Jenkins, B. Ogutu, 2018, EBioMedicine.

Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats.

B. Leonard, D. Horrobin, Cai Song, 2003, Journal of lipid research.

Stress and the immune system in the etiology of anxiety and depression

B. Leonard, Cai Song, 1996, Pharmacology Biochemistry and Behavior.

ALZHEIMER DISEASE: MALNUTRITION AND NUTRITIONAL SUPPORT

B. Leonard, E. Češková, Jirí Jarkovský, 2007 .

Platelets in Thrombotic and Non-thrombotic Disorders: Platelets in psychiatric and neurological disorders

B. Leonard, 2002 .

Pharmacokinetics of milnacipran in comparison with other antidepressants

B. Leonard, C. Puozzo, 1996, International clinical psychopharmacology.

THE BEHAVIOURAL EFFECTS OF MILNACIPRAN IN THE OLFACTORY BULBECTOMISED RAT MODEL OF DEPRESSION

J. Kelly, B. Leonard, A. Redmond, 1995 .

Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune functions in the olfactory bulbectomized rat

B. Leonard, Cai Song, 1994 .

Stress, the immune system, and psychiatry /

B. Leonard, K. Miller, 1995 .

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

J. Kelly, B. Leonard, T. Connor, 1999, European journal of pharmacology.

The effect of tianeptine and sertraline in three animal models of depression

J. Kelly, B. Leonard, 1994, Neuropharmacology.

Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1β in rats

B. Leonard, D. Horrobin, C. Song, 2004, Molecular Psychiatry.

The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat

J. Kelly, B. Leonard, J. Cryan, 1997, European Neuropsychopharmacology.

A review of the relevance and validity of olfactory bulbectomy as a model of depression

J. Kelly, B. Leonard, A. Harkin, 2003, Clinical Neuroscience Research.

Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain

J. Kelly, B. Leonard, T. Connor, 2000, Journal of Neural Transmission.

Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain.

B. Leonard, 1972, British journal of pharmacology.

Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.

B. Leonard, S. Tonge, 1972, Archives internationales de pharmacodynamie et de therapie.

Protective effects of exifone, a free radical scavenger, against ischaemia-induced hippocampal neurodegeneration in the gerbil

B. Leonard, B. Earley, M. Canney, 1994 .

Varying responses to the rat forced-swim test under diurnal and nocturnal conditions

J. Kelly, B. Leonard, C. Sánchez, 2000, Physiology & Behavior.

SAFETY OF AMOXAPINE

B. Leonard, 1989, The Lancet.

Behavioural and neurochemical interactions between chronic reserpine and chronic antidepressants. A possible model for the detection of atypical antidepressants.

B. Leonard, S. Jancsár, 1983, Biochemical pharmacology.

Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders

H. Möller, D. Stein, G. Goodwin, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Inflammation as the cause of the metabolic syndrome in depression.

B. Leonard, 2013, Modern trends in pharmacopsychiatry.

Effects of an oil enriched in gamma linolenic acid on locomotor activity and behaviour in the Morris Maze, following in utero ethanol exposure in rats.

B. Leonard, J. Menez, O. Duffy, 1992, Drug and alcohol dependence.

Effects of carnitine on changes caused by chronic administration of alcohol

B. Leonard, R. Corbett, 1984, Neuropharmacology.

Changes in “open field” behaviour and in some membrane-bound enzymes following the chronic administration of ethanol to the rat

B. Leonard, B. Keane, 1983, Neuropharmacology.

Some anatomical and physiological correlates of social isolation in the young rat

B. Leonard, A. Morinan, 1980, Physiology & Behavior.

The involvement of neuromediation in alcohol abuse and alcoholism

B. Leonard, 1995, Neurochemistry International.

Some persistent effects of the pre- and neonatal administration of psychotropic drugs on noradrenaline metabolism in discrete areas of rat brain.

B. Leonard, S. Tonge, 1973, British journal of pharmacology.

Neurochemical effects of fluphenazine decanoate in socially-reared and isolated young rats [proceedings].

B. Leonard, A. Morinan, 1979, British Journal of Pharmacology.

Test Conditions Influence the Response to a Drug Challenge in Rodents

J. O'Donnell, J. Kelly, B. Leonard, 2000, Pharmacology Biochemistry and Behavior.

The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function

B. Leonard, Cai Song, 1995 .

Biological aspects of depression: a review of the etiology and mechanisms of action and clinical assessment of antidepressants.

B. Leonard, S. Ankier, 1986, International review of neurobiology.

Sub‐types of serotonin receptors: biochemical changes and pharmacological consequences

B. Leonard, 1992, International clinical psychopharmacology.

The effects of chronic administration of ethanol on synaptosomal fatty acid composition: modulation by oil enriched with gamma-linolenic acid.

B. Leonard, F. Berthou, R. Corbett, 1992, Alcohol and alcoholism.

The effects of chronic ethanol administration on rat liver and erythrocyte lipid composition: modulatory role of 'evening primrose oil'.

B. Leonard, H. Floch, J. Menez, 1991, Alcohol and alcoholism.

The effect of chronic alcohol administration on platelet [3H]5-hydroxytryptamine uptake and membrane lipid composition

B. Leonard, J. Menez, R. Corbett, 1990, Neurochemistry International.

The Effect of Chronic Ethanol Administration on Neurotransmitter Metabolism in Rat Brain: Modification by Carnitine and Gamma Linolenic Acid

B. Leonard, R. Corbett, 1986 .

Possible relationships between thiamine, carnitine, polyunsaturated fatty acids and the neurotoxicity of alcohol.

B. Leonard, 1984, Alcohol and alcoholism.

Fast-Acting Antidepressants

Trevor R. Norman, B. Leonard, 1994 .

Increased 5HT‐induced platelet aggregation in mania: Lack of change following neuroleptic medication

B. Leonard, J. Meagher, 1994 .

Is the state of leucocyte adhesiveness/aggregation an immune marker of stress in the olfactory bulbectomized rat?

J. Kelly, B. Leonard, Cai Song, 1993 .

The effect of chronic administration of sodium barbitone on chemically and electrically induced convulsions in the rat.

B. Leonard, 1968, International journal of neuropharmacology.

The effect of chronic administration of barbitone sodium on the behaviour of the rat.

B. Leonard, 1967, International journal of neuropharmacology.

Platelet studies in panic disorder: A review

B. Leonard, D. Nugent, L. Mannion, 1997, Irish Journal of Psychological Medicine.

Long covid, neuropsychiatric disorders, psychotropics, present and future.

B. Leonard, D. Helmeste, S. Tang, 2022, Acta neuropsychiatrica.

Psychopathology of depression.

B. Leonard, 2007, Drugs of today.

Onset of the Effects of the 5-HT1A Antagonist, WAY-100635, Alone, and in Combination With Paroxetine, on Olfactory Bulbectomy and 8-OH-DPAT–Induced Changes in the Rat

Trevor R. Norman, B. Leonard, J. Cryan, 1999, Pharmacology Biochemistry and Behavior.

Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?

Trevor R. Norman, B. Leonard, J. Cryan, 1998, European journal of pharmacology.

NG‐Nitro‐L‐Arginine‐Methyl‐Ester Protects against Ischaemia‐Induced Biochemical Changes and Hippocampal Neurodegeneration in the Gerbil

B. Leonard, B. Earley, M. Caldwell, 1996 .

The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia.

J. Kelly, B. Leonard, B. Earley, 1995, European journal of pharmacology.

Neuroinflammation in Psychopathology

B. Leonard, 2016 .

On the mode of action of mianserin.

B. Leonard, 1982, Advances in biochemical psychopharmacology.

Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression

B. Leonard, W. O’Connor, 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

CHAPTER 10 – EFFECTS OF PSYCHOTROPIC DRUGS ON THE BEHAVIOR AND NEUROCHEMISTRY OF OLFACTORY BULBECTOMIZED RATS

B. Leonard, H. Riezen, 1991 .

Changes in the immune-endocrine interrelationships in anxiety and depression

B. Leonard, Cai Song, 1997 .

Effect of four amphetamines on brain biogenic amines and their metabolites.

B. Leonard, 1972, Biochemical pharmacology.

The role of catecholamines in the reversal of reserpine-induced hypothermia in mice by desipramine and chlorpromazine.

B. Leonard, H. Schnieden, F. Cooper, 1972, British journal of pharmacology.

Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain

B. Leonard, 2004, Psychopharmacologia.

Effect of D-amphetamine on the behaviour of rats in the open field apparatus: Interaction with four neuroleptics and changes in biogenic amine metabolsm in discrete brain regions

B. Leonard, M. Kenny, Marina Lynch, 1978, Irish journal of medical science.

An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression

F. Franconi, A. S. Wrynn, B. Leonard, 2000, Brain Research.

Clinical implications of mechanisms of action of antidepressants

B. Leonard, 2000 .

Chapter 9 Biological aspects of depression

B. Leonard, 2000 .

Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and β1-adrenergic receptors in an animal model of depression

J. Kelly, B. Leonard, A. Harkin, 2000, European Neuropsychopharmacology.

COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brain

B. Leonard, D. Helmeste, S. Tang, 2023, Acta Neuropsychiatrica.

Parallel changes in behaviour and hippocampal monoamine metabolism in rats after administration of ACTH-analogues

B. Leonard, H. Rigter, F. Ramaekers, 1978, Pharmacology Biochemistry and Behavior.

Parallel changes in behaviour and hippocampal serotonin metabolism in rats following treatment with desglycinamide lysine vasopressin

B. Leonard, H. Rigter, F. Ramaekers, 1977, Brain Research.

Antidepressant Compounds: A Critical Review

B. Leonard, D. Helmeste, S. Tang, 2010 .

Effect of Subchronic Antidepressant Treatments on Behavioral, Neurochemical, and Endocrine Changes in the Forced-Swim Test

J. Kelly, B. Leonard, T. Connor, 2000, Pharmacology Biochemistry and Behavior.

β-Amyloid-Induced Cholinergic Denervation Correlates with Enhanced Nitric Oxide Synthase Activity in Rat Cerebral Cortex: Reversal by NMDA Receptor Blockade

T. Harkany, B. Leonard, B. Penke, 1998, Brain Research Bulletin.

β-Amyloid(1-42)-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral Cortex

T. Harkany, J. Kelly, B. Leonard, 2001, Neurobiology of Disease.

University of Groningen β-Amyloid ( 1-42 )-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral Cortex

T. Harkany, J. Kelly, B. Leonard, 2018 .

Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex.

T. Harkany, J. Kelly, B. Leonard, 2001, Neurobiology of disease.

3,4‐methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose‐dependent neurochemical, endocrine and immune changes in the rat

J. Kelly, B. Leonard, T. Connor, 1999 .

Acute toxicity profile of maprotiline in the rat.

J. Kelly, B. Leonard, K. Dredge, 1999, Pharmacology & toxicology.

SSRIs, aggression and suicide – a cause for concern or the result of media hype?

B. Leonard, 2004, Irish Journal of Psychological Medicine.

Advances in the drug treatment of Alzheimer's Disease

B. Leonard, 1998 .

Effects of adrenocorticotrophin-(4-10)-heptapeptide on changes in brain monamine metabolism associated with retrograde amnesia in the rat.

B. Leonard, H. Rigter, F. Ramaekers, 1975, Biochemical Society transactions.

The effect of α‐melanocyte stimulating hormone (α‐MSH) on the metabolism of blogenlc amines in the rat brain

B. Leonard, S. Shuster, A. Thody, 1976 .

Stressor-induced alterations in serotonergic activity in an animal model of depression.

H. Anisman, B. Leonard, Cai Song, 1999, Neuroreport.

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

J. Kelly, B. Leonard, T. Connor, 1999 .

Protective Effects of Vanoxeamine (GBR 12909) Against Ischaemia-Induced Hyperactivity and Neurodegeneration in the Gerbil Model of Cerebral Ischaemia

J. Kelly, B. Leonard, M. Maginn, 1997, Pharmacology Biochemistry and Behavior.

Neuropsychopharmacology: Changing the Face of Psychotropic Drug Discovery

B. Leonard, B. E. Leonard, 1997, CNS Spectrums.

‘Schizophrenia and Diabetes 2003’ Expert Consensus Meeting, Dublin, 3–4 October 2003: Consensus summary

B. Leonard, T. Dinan, S. Gough, 2004, British Journal of Psychiatry.

The effects of amitriptyline, mianserin, phenoxybenzamine and propranolol on the release of noradrealine in the rat brain in vivo.

B. Leonard, J. Fludder, 1979, Biochemical pharmacology.

Partial antagonism of the behavioural and neurochemical effects of phencyclidine by drugs affecting monoamine metabolism

B. Leonard, S. Tonge, 2004, Psychopharmacologia.

Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress?

B. Leonard, B. Earley, C. Song, 1995, Annals of the New York Academy of Sciences.

Research report Tryptophan breakdown pathway in bipolar mania

B. Leonard, Sun-Hwa Park, Y. Kim, 2007 .

Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat.

B. Leonard, C. Song, 1995, Neuroimmunomodulation.

Phencyclidine prevents spatial navigation and passive avoidance deficits in ibotenate lesioned rats

B. Leonard, B. Earley, A. O'Connell, 1994, Neuropharmacology.

Comprehensive Textbook of Psychiatry. 7th Edition, 2 volumes. Edited by Bergamin J. Sadock and Virgina A. Sadock, Lippincott, William and Wilkins, 1999. Pages: 3500. US$249

B. Leonard, 2000 .

Endocoids in depression: Do antidepressants alter endocoids that affect the serotonergic system?

B. Leonard, 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In search of black bile: do antidepressants act by changing endogenous endocoids in the depressed patient?

B. Leonard, 1993, Journal of psychopharmacology.

Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression

B. Leonard, J. Brophy, C. McAdams, 1992, Biological Psychiatry.

Hallucinogens and non-hallucinogens: a comparison of the effects on 5-hydroxytryptamine and noradrenaline.

B. Leonard, S. Tonge, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

Rodent models of alcoholism: a review.

B. Leonard, B Keane, B E Leonard, 1989, Alcohol and alcoholism.

Pro-inflammatory Cytokines and the Depressive Phenotype

B. Leonard, F. Aricioglu, C. Ozkartal, 2021, Immuno-Psychiatry.

The Effects of Central Administration of Neuropeptide Y on Behavior, Neurotransmitter, and Immune Functions in the Olfactory Bulbectomized Rat Model of Depression

B. Leonard, Cai Song, B. Earley, 1996, Brain, Behavior, and Immunity.

NG-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil.

B. Leonard, B. Earley, M. Caldwell, 1994, European journal of pharmacology.

Pharmacological effects of serotonin reuptake inhibitors.

B. Leonard, 1988, The Journal of clinical psychiatry.

Some neurochemical and neuropharmacological studies on the interactions between mescaline and 1-methyl-1,2,5,6-tetrahydropyridine-3-(N,N-diethylcarboxamide) (THPC)

B. Leonard, P. Stonier, 2004, Psychopharmacologia.

The effect of some hallucinogenic and other drugs on the temperature of reserpinized mice

B. Leonard, P. Stonier, 2004, Psychopharmacologia.

5-HYDROXY-TRYPTAMINE IN THE BRAIN

B. Leonard, S. Tonge, 1969 .

The novel σ ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil

B. Leonard, B. Earley, J. Junien, 1996, Neurochemistry International.

Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.

B. Leonard, F. Hasan, 1981, Neuropharmacology.

The effect of acute MDMA administration on body temperature, serum corticosterone and neurotransmitter concentrations in male and female rats

J. Kelly, B. Leonard, M. McNamara, 1995 .

Neuropharmacology of antidepressants that modify central noradrenergic and serotonergic function: a short review

B. Leonard, B. E. Leonard, 1999 .

New developments in the pharmacological treatment of anxiety

B. Leonard, 1999 .

The effect of treatment with a new antidepressant: INN 00835 on platelet serotonin uptake in depressed patients

J. Feighner, B. Leonard, L. Sverdlov, 1998, European Neuropsychopharmacology.

The characterization of oxotremorine-induced hypothermic response in the rat.

J. Kelly, B. Leonard, P. Ryan, 1996, Pharmacology & toxicology.

CANNABINOIDS AND NEUROINFLAMMATION: THERAPEUTIC IMPLICATIONS

B. Leonard, F. Aricioglu, 2023, Journal of Affective Disorders Reports.

A review of the role of serotonin receptors in psychiatric disorders

B. Leonard, M. Naughton, Jane B. Mulrooney, 2000, Human psychopharmacology.

Managing interactions between cognitive enhancers and other psychotropics

B. Leonard, S. Tang, W. Tang, 2017, International clinical psychopharmacology.

The effect of some beta-adrenoceptive blocking drugs on glucose-6-phosphate and fructose-1,6-phosphate levels, and on hexokinase activity in the mouse brain.

B. Leonard, W. D. Watkinson, 1971, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients.

J. Feighner, J. Kelly, B. Leonard, 1999 .

Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300217-JLR200

B. Leonard, D. Horrobin, Cai Song, 2003, Journal of Lipid Research.

Variation in hydroxytryptamine metabolism in the rat: effects on the neurochemical response to phencyclidine

B. Leonard, S. Tonge, B. E. Leonard, 1971, The Journal of pharmacy and pharmacology.

Forced Swim Test-Induced Endocrine and Immune Changes in the Rat: Effect of Subacute Desipramine Treatment

J. Kelly, B. Leonard, T. Connor, 1998, Pharmacology Biochemistry and Behavior.

The effect of Δ1,6 tetrahydrocannabinol on biogenic amines and their amino acid precursors in the rat brain

B. Leonard, 1971 .

Fundamentals of Psychoneuroimmunology

B. Leonard, Cai Song, 2000 .

Metyrapone displays antidepressant-like properties in preclinical paradigms

J. Kelly, B. Leonard, J. Cryan, 1999, Psychopharmacology.

The Determination of the Optimal Dose of Milnacipran in the Olfactory Bulbectomized Rat Model of Depression

J. Kelly, B. Leonard, A. Redmond, 1999, Pharmacology Biochemistry and Behavior.

Changes in Behaviour, Neurotransmitters and Neutrophil Function in Olfactory Bulbectomized Rats: Effects of Chronic Desipramine Treatment

B. Leonard, Cai-Yun Song, Cai Song, 1997 .

Some behavioural and neurochemical effects of ipsapirone in two rodent models of depression

J. Kelly, B. Leonard, M. McNamara, 1996, Journal of psychopharmacology.

Effects of chronic desipramine on waiting behaviour for a food reward in olfactory bulbectomized rats

J. Kelly, B. Leonard, 1996, Journal of psychopharmacology.

The effect of a putative antidepressant, an o2-substituted derivative of barbitone on apomorphine induced hypomotility

B. Leonard, J. Menez, 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The effect of (±)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat

B. Leonard, S. Jancsár, 1984, Neuropharmacology.

Chronic effects of miaserin on noradrenaline metabolism in the rat brain: Evidence for a pre-synaptic α-adrenolytic action in vivo

B. Leonard, J. Fludder, 1979, Psychopharmacology.

Changes in brain monoamine metabolism associated with CO2-induced amnesia in rats.

B. Leonard, H. Rigter, 1973, British journal of pharmacology.

Circadian Abnormalities in Platelet 5-HT Reuptake in Depression

B. Leonard, D. Healy, P. A. Carney, 1985 .

ADAPTATIONAL CHANGES IN AMINE RECEPTORS AND SEROTONIN UPTAKE FOLLOWING ANTIDEPRESSANT TREATMENT: COMPARISON BETWEEN TRAZODONE AND AMITRIPTYLINE IN DEPRESSED PATIENTS

B. Leonard, D. Healy, P. A. Carney, 1984 .

Quantitative autoradiographic analysis of muscarinic receptors and quantitative histochemistry of acetylcholinesterase in the rat brain after trimethyltin intoxication

B. Leonard, A. Biegon, B. Earley, 1989, Neurochemistry International.

The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat.

J. Kelly, B. Leonard, P. Ryan, 2001, Pharmacology & toxicology.

Increased membrane-bound polyribosome fraction in the brains of rats with hereditary diabetes insipidus

B. Leonard, H. Rigter, F. Ramaekers, 1977, Experientia.

Classification of Psychoactive Drugs

B. Leonard, 2014 .

Changes in whole brain membranes of rats following pre- and post-natal exposure to ethanol.

B. Leonard, H. Floch, J. Menez, 1991, Alcohol and alcoholism.

Inflammation, insulin resistance and neuroprogression in depression

B. Leonard, G. Wegener, 2019, Acta Neuropsychiatrica.

Advances in the drug treatment of Alzheimer's Disease

B. Leonard, 1998 .

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

J. Lieberman, J. Markowitz, S. Kanba, 2007, The international journal of neuropsychopharmacology.

Inflammation and depression: a causal or coincidental link to the pathophysiology?

B. Leonard, 2017, Acta Neuropsychiatrica.

Pain, Depression and Inflammation: Are Interconnected Causative Factors Involved?

B. Leonard, 2015, Modern trends in pharmacopsychiatry.

Interactions among memory‐related centers in the brain

B. Leonard, S. Shu, Yong-ming Wu, 2003, Journal of neuroscience research.

Post-partum depression and the effect of nomifensine treatment.

B. Leonard, J. Butler, 1986, International clinical psychopharmacology.

Litigation and the toxicity of psychotropic drugs: A reply to Prof Patricia Casey

B. Leonard, 1996, Irish Journal of Psychological Medicine.

5HT receptor subtypes in anxiety disorders and depression

B. Leonard, 1993, European Neuropsychopharmacology.

Time-dependent aspects of CO2 induced amnesia and hippocampal monoamine metabolism in rats

B. Leonard, H. Rigter, G. Eys, 1975, Pharmacology Biochemistry and Behavior.

The effects of castration and hormone replacement on runway behaviour and GABA concentrations in the septum

B. Leonard, C. Earley, 1979, Irish journal of medical science.

Depression: From Psychopathology to Pharmacotherapy

B. Leonard, J. Cryan, 2010 .

The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain.

B. Leonard, W. F. Kafoe, 1973, Archives internationales de pharmacodynamie et de therapie.

Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs

B. Leonard, M. Kenny, 1980, Journal of neuroscience research.

Royal academy of medicine in Ireland section of biomedical sciences

T. McDonnell, J. Kelly, B. Leonard, 1994 .

Principles of neural science, third edition. By E. R. Kandel, J. H. Schwartz and T. M. Jessell. Appleton & Lange, 1991. pp. 1135 + xxxvii. ISBN 0‐8385‐8068‐8

B. Leonard, B. E. Leonard, 1993 .

A Study of the Neurohumoral Control of Glycolysis in the Mouse Brain in vivo: Role of Noradrenaline and Dopamine

B. Leonard, 1975, Zeitschrift fur Naturforschung. Section C, Biosciences.

Changes in platelet aggregatory responses to collagen and 5‐hydroxytryptamine in depressed, schizophrenic and manic patients

B. Leonard, C. McAdams, 1992, International clinical psychopharmacology.

Royal academy of medicine in ireland section of biological sciences

J. Mcgeown, J. Kelly, B. Leonard, 1990 .

Effects of prior exposure on conditioned taste aversion in the rat: androgen- and estrogen-dependent events.

B. Leonard, C. Earley, 1979, Journal of comparative and physiological psychology.